Yurttancikmaz E, Ozcan P, Tanoglu F, Tok O, Timur H, Cetin C
Gynecol Obstet Invest. 2024; 89(2):120-130.
PMID: 38253037
PMC: 11126202.
DOI: 10.1159/000536055.
Rosario R, Stewart H, Spears N, Telfer E, Anderson R
Hum Reprod. 2023; 39(2):382-392.
PMID: 38070496
PMC: 10833070.
DOI: 10.1093/humrep/dead255.
Lee D, Song W, Lim Y, Lee C, Rajbongshi L, Hwang S
Mar Drugs. 2023; 21(10).
PMID: 37888466
PMC: 10608061.
DOI: 10.3390/md21100531.
Li G, Gu J, Zhou X, Wu T, Li X, Hua R
Front Endocrinol (Lausanne). 2023; 14:1122012.
PMID: 37033217
PMC: 10081448.
DOI: 10.3389/fendo.2023.1122012.
Fang C, Ye Y, Yang F, Wang F, Shen Y, Chang D
Front Pharmacol. 2023; 13:1040544.
PMID: 36588705
PMC: 9794755.
DOI: 10.3389/fphar.2022.1040544.
Effects of collagen peptides from skin on oxidative damage induced by cyclophosphamide in mice.
Han M, Zhang Z, Li X, Tong H, Xu Z, Ding Z
Front Nutr. 2022; 9:1037212.
PMID: 36407538
PMC: 9669612.
DOI: 10.3389/fnut.2022.1037212.
Red propolis reduces inflammation in cyclophosphamide-induced hemorrhagic cystitis in rats.
Melo N, De Sousa Peres Junior H, Araujo Diniz C, Silva M, Gomes de Lemos T, Jamacaru F
Biomedica. 2022; 42(2):253-263.
PMID: 35867919
PMC: 9365036.
DOI: 10.7705/biomedica.6087.
β-Caryophyllene Ameliorates Cyclophosphamide Induced Cardiac Injury: The Association of TLR4/NFκB and Nrf2/HO1/NQO1 Pathways.
Younis N
J Cardiovasc Dev Dis. 2022; 9(5).
PMID: 35621844
PMC: 9145742.
DOI: 10.3390/jcdd9050133.
Crosstalk between anticancer drugs and mitochondrial functions.
Sahu K, Langeh U, Singh C, Singh A
Curr Res Pharmacol Drug Discov. 2021; 2:100047.
PMID: 34909674
PMC: 8663961.
DOI: 10.1016/j.crphar.2021.100047.
The Role of METTL3-Mediated N6-Methyladenosine (m6A) of JPH2 mRNA in Cyclophosphamide-Induced Cardiotoxicity.
Zhu M, Liu Y, Song Y, Zhang S, Hang C, Wu F
Front Cardiovasc Med. 2021; 8:763469.
PMID: 34820430
PMC: 8606687.
DOI: 10.3389/fcvm.2021.763469.
Antiproliferative, Apoptotic Effects and Suppression of Oxidative Stress of Quercetin against Induced Toxicity in Lung Cancer Cells of Rats: and Study.
Zhaorigetu , Farrag I, Belal A, Al Badawi M, Abdelhady A, Abou Galala F
J Cancer. 2021; 12(17):5249-5259.
PMID: 34335941
PMC: 8317526.
DOI: 10.7150/jca.52088.
Hidrox Counteracts Cyclophosphamide-Induced Male Infertility through NRF2 Pathways in a Mouse Model.
Fusco R, Salinaro A, Siracusa R, DAmico R, Impellizzeri D, Scuto M
Antioxidants (Basel). 2021; 10(5).
PMID: 34068924
PMC: 8156985.
DOI: 10.3390/antiox10050778.
Cyclophosphamide exposure assessed with the biomarker phosphoramide mustard-hemoglobin in breast cancer patients: The TailorDose I study.
Gernaat S, von Stedingk H, Hassan M, Nilsson H, Rodriguez-Wallberg K, Hedayati E
Sci Rep. 2021; 11(1):2707.
PMID: 33526812
PMC: 7851165.
DOI: 10.1038/s41598-021-81662-1.
An enolase inhibitor for the targeted treatment of ENO1-deleted cancers.
Lin Y, Satani N, Hammoudi N, Yan V, Barekatain Y, Khadka S
Nat Metab. 2020; 2(12):1413-1426.
PMID: 33230295
PMC: 7744354.
DOI: 10.1038/s42255-020-00313-3.
Alogliptin: a novel approach against cyclophosphamide-induced hepatic injury via modulating SIRT1/FoxO1 pathway.
Salama R, Mohamed A, Hamed N, Ata R, NourelDeen A, Hassan M
Toxicol Res (Camb). 2020; 9(4):561-568.
PMID: 32905193
PMC: 7467234.
DOI: 10.1093/toxres/tfaa059.
Transient Effects of Cyclophosphamide on Basal Cell Proliferation of Olfactory Epithelia.
Joseph K, Awadallah N, Delay E, Delay R
Chem Senses. 2020; 45(7):549-561.
PMID: 32531016
PMC: 7545251.
DOI: 10.1093/chemse/bjaa039.
Cyclophosphamide has Long-Term Effects on Proliferation in Olfactory Epithelia.
Awadallah N, Proctor K, Joseph K, Delay E, Delay R
Chem Senses. 2019; 45(2):97-109.
PMID: 31844905
PMC: 7446702.
DOI: 10.1093/chemse/bjz075.
A curative combination cancer therapy achieves high fractional cell killing through low cross-resistance and drug additivity.
Palmer A, Chidley C, Sorger P
Elife. 2019; 8.
PMID: 31742555
PMC: 6897534.
DOI: 10.7554/eLife.50036.
Ovarian Follicle Depletion Induced by Chemotherapy and the Investigational Stages of Potential Fertility-Protective Treatments-A Review.
Hao X, Anastacio A, Liu K, Rodriguez-Wallberg K
Int J Mol Sci. 2019; 20(19).
PMID: 31548505
PMC: 6801789.
DOI: 10.3390/ijms20194720.
Human constitutive androstane receptor agonist DL5016: A novel sensitizer for cyclophosphamide-based chemotherapies.
Liang D, Li L, Lynch C, Mackowiak B, Hedrich W, Ai Y
Eur J Med Chem. 2019; 179:84-99.
PMID: 31247375
PMC: 6718324.
DOI: 10.1016/j.ejmech.2019.06.031.